Harvey R, Faulkes R, Gillett P, Lindsay N, Paucha E, Bradbury A, Smith A E
EMBO J. 1982;1(4):473-7. doi: 10.1002/j.1460-2075.1982.tb01193.x.
A peptide Tyr.Arg.Asp.Leu.Lys.Leu corresponding to the carboxy-terminal six amino acids of small-t antigen predicted from the DNA sequence of SV40 was synthesised, coupled to bovine serum albumin and to ovalbumin and used to raise antibody in rabbits. The sera obtained immunoprecipitated [125I]peptide. It also recognised SV40 small-t that was synthesised in vitro from SV40 mRNA or extracted from SV40 infected monkey cells. The immunoprecipitation of small-t was inhibited by added peptide. To demonstrate that the determinant was present at the carboxy-terminal end of the molecule, truncated versions of small-t coded for by 0.54-0.59 deletion mutants were tested. dl 890 small-t, which contains an in-phase deletion removing nine amino acids but leaving the carboxy-terminal sequences intact, was recognised by the antipeptide serum. By contrast dl 885 small-t, which has an out-of-phase deletion leading to an altered carboxy terminus coded in an alternative reading frame, was not recognised. The data confirm the location and specificity of the determinant recognised on small-t by the antipeptide serum.
合成了一种对应于从SV40的DNA序列预测的小t抗原羧基末端六个氨基酸的肽Tyr.Arg.Asp.Leu.Lys.Leu,将其与牛血清白蛋白和卵清蛋白偶联,并用于在兔中产生抗体。所获得的血清免疫沉淀了[125I]肽。它还识别从SV40 mRNA体外合成或从感染SV40的猴细胞中提取的SV40小t。添加的肽抑制了小t的免疫沉淀。为了证明该决定簇存在于分子的羧基末端,测试了由0.54 - 0.59缺失突变体编码的小t的截短版本。dl 890小t包含一个移码缺失,去除了九个氨基酸但羧基末端序列完整,被抗肽血清识别。相比之下,dl 885小t有一个移码缺失,导致在另一个阅读框中编码的羧基末端改变,未被识别。这些数据证实了抗肽血清在小t上识别的决定簇的位置和特异性。